| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | BUY | NEUTRAL | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.23▼ | 1.22▲ | 1.22▼ | 1.18▲ | 1.22▲ |
| MA10 | 1.23▼ | 1.22▼ | 1.23▼ | 1.17▲ | 1.22▲ |
| MA20 | 1.22▼ | 1.22▼ | 1.21▲ | 1.21▲ | 1.20▲ |
| MA50 | 1.22▼ | 1.19▲ | 1.15▲ | 1.22▲ | 1.48▼ |
| MA100 | 1.23▼ | 1.15▲ | 1.19▲ | 1.21▲ | 2.29▼ |
| MA200 | 1.21▲ | 1.19▲ | 1.25▼ | 1.38▼ | 4.96▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.003▼ | -0.002▼ | 0.002▲ | 0.032▲ |
| RSI | 45.501▼ | 53.456▲ | 58.185▲ | 51.905▲ | 46.938▼ |
| STOCH | 87.500▲ | 30.060 | 37.544 | 49.294 | 36.644 |
| WILL %R | -75.000▼ | -76.923▼ | -41.667 | -29.630 | -55.566 |
| CCI | -53.272 | -32.046 | 17.066 | 58.616 | 18.239 |
|
Monday, November 10, 2025 05:35 AM
Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/11/25 | 1.26 | 1.27 | 1.205 | 1.23 | 2,429,101 |
| 11/11/25 | 1.16 | 1.27 | 1.15 | 1.24 | 2,280,789 |
| 10/11/25 | 1.23 | 1.23 | 1.1602 | 1.18 | 2,480,517 |
| 07/11/25 | 1.05 | 1.18 | 1.04 | 1.18 | 3,138,038 |
| 06/11/25 | 1.105 | 1.105 | 1.05 | 1.05 | 2,716,285 |
| 05/11/25 | 1.14 | 1.14 | 1.08 | 1.11 | 1,765,635 |
| 04/11/25 | 1.16 | 1.175 | 1.05 | 1.11 | 2,138,503 |
| 03/11/25 | 1.25 | 1.26 | 1.17 | 1.18 | 2,098,226 |
| 31/10/25 | 1.25 | 1.28 | 1.21 | 1.24 | 1,645,235 |
| 30/10/25 | 1.21 | 1.26 | 1.21 | 1.21 | 1,243,587 |
|
|
||||
|
|
||||
|
|